Dong-A St

KO:170900 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$274.42 Million
₩401.81 Billion KRW
Market Cap Rank
#16603 Global
#525 in Korea
Share Price
₩43850.00
Change (1 day)
+0.80%
52-Week Range
₩41200.00 - ₩57800.00
All Time High
₩155894.20
About

Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products in South Korea and internationally. It offers various ethical drugs, including Clofazimine cap. For lepromatous leprosy; Closerin Cap for active pulmonary and extra-pulmonary tuberculosis; Eporon inj./PFS for anemia associated with chronic renal failure; Gemcit inj. to treat non-small cell lung, pancreatic, breast, bl… Read more

Dong-A St (170900) - Total Assets

Latest total assets as of September 2025: ₩1.42 Trillion KRW

Based on the latest financial reports, Dong-A St (170900) holds total assets worth ₩1.42 Trillion KRW as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Dong-A St - Total Assets Trend (2013–2024)

This chart illustrates how Dong-A St’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Dong-A St - Asset Composition Analysis

Current Asset Composition (December 2024)

Dong-A St's total assets of ₩1.42 Trillion consist of 42.2% current assets and 57.8% non-current assets.

Asset Category Amount (KRW) % of Total Assets
Cash & Equivalents ₩0.00 13.2%
Accounts Receivable ₩112.36 Billion 8.1%
Inventory ₩141.75 Billion 10.2%
Property, Plant & Equipment ₩0.00 0.0%
Intangible Assets ₩136.08 Billion 9.8%
Goodwill ₩22.00 Billion 1.6%

Asset Composition Trend (2013–2024)

This chart illustrates how Dong-A St's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Dong-A St's current assets represent 42.2% of total assets in 2024, an increase from 37.4% in 2013.
  • Cash Position: Cash and equivalents constituted 13.2% of total assets in 2024, down from 14.2% in 2013.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 1.0% in 2013.
  • Asset Diversification: The largest asset category is inventory at 10.2% of total assets.

Dong-A St Competitors by Total Assets

Key competitors of Dong-A St based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Kamada
NASDAQ:KMDA
USA $378.79 Million
One World Pharma Inc
OTCQB:OWPC
USA $6.62 Million
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million

Dong-A St - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.50 - 0.62

Moderate asset utilization - Dong-A St generates 0.50x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -0.60% - 7.03%

Negative ROA - Dong-A St is currently not profitable relative to its asset base.

Dong-A St - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.53 2.26 3.13
Quick Ratio 1.14 1.81 2.42
Cash Ratio 0.00 0.00 0.00
Working Capital ₩215.21 Billion ₩ 353.73 Billion ₩ 314.53 Billion

Dong-A St - Advanced Valuation Insights

This section examines the relationship between Dong-A St's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.78
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 10.1%
Total Assets ₩1.39 Trillion
Market Capitalization $145.02 Million USD

Valuation Analysis

Below Book Valuation: The market values Dong-A St's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Dong-A St's assets grew by 10.1% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Dong-A St (2013–2024)

The table below shows the annual total assets of Dong-A St from 2013 to 2024.

Year Total Assets Change
2024-12-31 ₩1.39 Trillion +10.07%
2023-12-31 ₩1.26 Trillion +9.22%
2022-12-31 ₩1.16 Trillion +3.74%
2021-12-31 ₩1.12 Trillion +13.80%
2020-12-31 ₩980.67 Billion -2.79%
2019-12-31 ₩1.01 Trillion +6.34%
2018-12-31 ₩948.67 Billion +5.44%
2017-12-31 ₩899.72 Billion -15.65%
2016-12-31 ₩1.07 Trillion +0.29%
2015-12-31 ₩1.06 Trillion -1.69%
2014-12-31 ₩1.08 Trillion +16.11%
2013-12-31 ₩931.72 Billion --